头皮毛母质癌并腮腺淋巴结转移1例 - betway必威登陆网址

国际肿瘤学杂志››2023,Vol. 50››Issue (2): 126-128.doi:10.3760/cma.j.cn371439-20220328-00026

• 病例报道 •上一篇

头皮毛母质癌并腮腺淋巴结转移1例

梁鑫, 金风(), 李媛媛()

贵州医科大学附属肿瘤医院头颈肿瘤科，贵阳 550001

收稿日期:2022-03-28修回日期:2022-06-20出版日期:2023-02-08发布日期:2023-03-22
通讯作者:金风，Email： jinf8865@yeah.net ；李媛媛，Email： 1244028717@qq.com

Received:2022-03-28Revised:2022-06-20Online:2023-02-08Published:2023-03-22

摘要/Abstract

摘要：

毛母质癌是一种非常罕见的低度恶性肿瘤，具有基质分化的特点，由于临床上极为罕见，极易漏诊、误诊，目前尚缺乏标准的治疗方案。现报道1例头皮毛母质癌并腮腺淋巴结转移患者，在术后进行放疗及顺铂同步增敏治疗后，局部转移病灶取得了完全缓解。

梁鑫, 金风, 李媛媛. 头皮毛母质癌并腮腺淋巴结转移1例[J]. 国际肿瘤学杂志, 2023, 50(2): 126-128.

图/表2

参考文献11

[1]	Weng G, Li F, Xu M. Pilomatrix carcinoma of the male breast: a case report[J]. Int J Clin Exp Pathol, 2020, 13(8): 2153-2157.
[2]	Lopansri S, Mihm MC Jr. Pilomatrix carcinoma or calcifying epitheliocarcinoma of Malherbe: a case report and review of literature[J]. Cancer, 1980, 45(9): 2368-2373. DOI: 10.1002/1097-0142. doi:10.1002/1097-0142pmid:7379033
[3]	White C, Farsi M, Esguerra D, et al. Not your average skin cancer: a rare case of pilomatrix carcinoma[J]. J Clin Aesthet Dermatol, 2020, 13(6): 40-42.
[4]	Melancon JM, Tom WL, Lee RA, et al. Management of pilomatrix carcinoma: a case report of successful treatment with Mohs micrographic surgery and review of the literature[J]. Dermatol Surg, 2011, 37(12): 1798-1805. DOI: 10.1111/j.1524-4725.2011.02170.x. doi:10.1111/j.1524-4725.2011.02170.xpmid:22093235
[5]	Alcántara-González J, Sánchez-Largo ME, Caminoa A, et al. Pilomatrix carcinoma: a rare cause of facial tumor[J]. Dermatol Online J, 2014, 20(7): 13030/qt5ct4m4w1. DOI: 10.5070/D3207023135. doi:10.5070/D3207023135
[6]	Lazar AJ, Calonje E, Grayson W, et al. Pilomatrix carcinomas contain mutations in CTNNB1, the gene encoding beta-catenin[J]. J Cutan Pathol, 2005, 32(2): 148-157. DOI: 10.1111/j.0303-6987.2005.00267.x. doi:10.1111/j.0303-6987.2005.00267.xpmid:15606674
[7]	Aherne NJ, Fitzpatrick DA, Gibbons D, et al. Recurrent malignant pilomatrixoma invading the cranial cavity: improved local control with adjuvant radiation[J]. J Med Imaging Radiat Oncol, 2009, 53(1): 139-141. DOI: 10.1111/j.1754-9485.2009.02049.x. doi:10.1111/j.1754-9485.2009.02049.x
[8]	Papadakis M, de Bree E, Floros N, et al. Pilomatrix carcinoma: more malignant biological behavior than was considered in the past[J]. Mol Clin Oncol, 2017, 6(3): 415-418. DOI: 10.3892/mco.2017.1148. doi:10.3892/mco.2017.1148pmid:28451423
[9]	Ng WT, Lee MC, Chang AT, et al. The impact of dosimetric in-adequacy on treatment outcome of nasopharyngeal carcinoma with IMRT[J]. Oral Oncol, 2014, 50(5): 506-512. DOI: 10.1016/j.oraloncology.2014.01.017. doi:10.1016/j.oraloncology.2014.01.017
[10]	Thamlikitkul L, Petsuksiri J, Ithimakin S. Post-operative concurrent chemoradiation for patients with non-squamous cell carcinoma of head and neck: a retrospective cohort of the uncommon cancers[J]. Asian Pac J Cancer Prev, 2019, 20(6): 1727-1734. DOI: 10.31557/APJCP.2019.20.6.1727. doi:10.31557/APJCP.2019.20.6.1727
[11]	Onderdonk BE, Vokes EE, Gwede M, et al. Adjuvant treatment for high-risk salivary gland malignancies and prognostic stratification based on a 20-year single institution experience[J]. Health Sci Rep, 2020, 3(4): e195. DOI: 10.1002/hsr2.195. doi:10.1002/hsr2.195pmid:33043152

相关文章15

编辑推荐

Metrics

本文评价